Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays

Hepatology

Volumn 31, Issue 5, 2000, Pages 1176-1182

  Ireland, Jacqueline H ^a   O'Donnell, Barbara ^a   Basuni, Ashraf A ^a   Kean, Joy D ^a   Wallace, Lesley A ^a   Lau, George K K ^b   Carman, William F ^a,c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ANTIGENIC VARIATION; ARTICLE; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; HEPATITIS B; PRIORITY JOURNAL; PROTEIN VARIANT; VIREMIA;

EID: 0034016158     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/he.2000.6407     Document Type: Article

References (12)

1. Wallace LA, Carman WE Surface gene variation of HBV: scientific and medical relevance. Viral Hepatitis Reviews 1997;3:5-16.
2. Howard CR. The structure of hepatitis B envelope and molecular variants of hepatitis B virus. J Vir Hepat 1995;2:165-170.
3. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S gene. Intervirology 1995;38:24-34.
4. Carman WF, Korula J, Wallace, L MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995;345:1406-1407.
5. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994;68:2671-2676.
6. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-329.
7. Oon C-J, Lim G-K, Ye Z, Goh KT, Tan KL, Yo SL, Hopes E, et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995;13:669-702.
8. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 1992;32:264-268.
9. Hawkins AE, Gilson RJC, Gilbert N, Wreghitt TG, Gray JJ, Ahlers-de Boer I, Tedder RS, et al. Hepatitis B virus surface mutations associated with infection after liver transplantation. J Hepatol 1996;24:8-14.
10. Carman WF, Owsianka A, Wallace LA, Dow LA, Mutimer DJ. Antigenic characterisation of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hyperimmuneglobulin. J Hepatol 1999;31:195-201.
11. Ghany MG, Ayola B, Villamil FG, Gish R, Roiter S, Vierling JM, Lok ASF Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. HEPATOLOGY 1998;27:213-222.
12. McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavia D, Tolpin MD, Nadler PI, et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. HEPATOLOGY 1992;15:757-766.